Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
SomaLogic revenue
SomaLogic's revenue is $97.7 million.
What is SomaLogic's revenue?
- SomaLogic's revenue growth from 2020 to 2022 is 74.75%.
- SomaLogic has 235 employees, and the revenue per employee ratio is $415,600.
- SomaLogic's peak quarterly revenue was $41.7M in 2022(q3).
- SomaLogic peak revenue was $97.7M in 2022.
- SomaLogic annual revenue for 2021 was 81.6M, 46.05% growth from 2020.
- SomaLogic annual revenue for 2022 was 97.7M, 19.65% growth from 2021.
On this page
Zippi applies for you, and finds you a job.
SomaLogic historical revenue
SomaLogic's peak revenue was $97.7M in 2022. The peak quarterly revenue was $41.7M in 2022(q3).
SomaLogic's revenue increased from $55.9m in 2020 to $97.7M currently. That's a 74.75% change in annual revenue.
SomaLogic annual revenue
SomaLogic annual revenue over time
| Fiscal year / year | SomaLogic revenue |
|---|---|
| 2020 | $55.9M |
| 2021 | $81.6M |
| 2022 | $97.7M |
SomaLogic quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
SomaLogic quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | - | $20.0M | $23.0M |
| 2022 | $23.0M | $14.1M | $41.7M | $18.8M |
| 2023 | $20.4M | $20.5M | $22.0M | - |
SomaLogic jobs nearby
Do you work at SomaLogic?
Did SomaLogic meet its revenue projections?
SomaLogic financial information
| CEO | Roy Smythe |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 235 |
| Date Founded | 1999 |
| Headquarters | Boulder, Colorado |
| Revenue | $97.7M |
| Net Income | -$109,157,000 |
| Gross Proft | $54.3M (2022) |
| Tax Rate | 0.0% |
| Total Assets | $647,374,000 |
| Ticker | SLGC |
SomaLogic jobs you might like
SomaLogic financing
SomaLogic received early financing of $8.0M on 2002-07-22.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $8M | 07/2002 |
| Series Unknown | $19.5M | 01/2003 |
| Series Unknown | $5.0M | 11/2003 |
| Series Unknown | $2M | 05/2007 |
| Series Unknown | $2M | 10/2007 |
| Series Unknown | $35.0M | 04/2008 |
| Series Unknown | $5.0M | 08/2010 |
| Series A | $15.0M | 11/2010 |
| Series Unknown | $10M | 08/2013 |
| Grant | $1M | 06/2014 |
| Series Unknown | $16.5M | 11/2014 |
| Debt Financing | $60.5M | 03/2016 |
| Series Unknown | $200M | 01/2018 |
| Series A | $121M | 11/2020 |
| Series A | $81M | 12/2020 |
| Post Ipo Equity | $375M | 09/2021 |
SomaLogic investors
| Investors | Security type |
|---|---|
| Bill & Melinda Gates Foundation | Grant |
| ProQuest Investments | Series Unknown |
| Visium Healthcare Partners | Debt Financing |
| Visium Healthcare Partners | Series Unknown |
| Madryn Asset Management | Series Unknown |
| Nan Fung Life Sciences | Series Unknown |
| Quest Diagnostics Incorporated | Series Unknown |
| OTSUKA PHARMACEUTICAL CO LTD | Series Unknown |
| ProQuest Investments | Series Unknown |
| iCarbonX | Series Unknown |
| Madryn Asset Management | Series A |
| Soleus Capital LLC | Series A |
| Monashee Investment Management LLC | Series A |
| Mossrock Capital | Series A |
| Fiscus Ventures | Series A |
| Blue Water Life Science Fund LP | Series A |
| Foresite Capital | Series A |
| T. Rowe Price | Series A |
| Casdin Capital | Series A |
| Farallon Capital Management | Series A |
| Reimagined Ventures | Series A |
| Ziff Capital Partners LLC | Series A |
| Novartis | Series A |
| Logos Capital | Series A |
| Redmile Group | Series A |
| Boston Millennia Partners | Series A |
| NEC Solution Innovators | Series A |
| Millennium Management | Series A |
| Intermountain Ventures | Series A |
| Janus Henderson Investors | Series A |
| Amgen | Series A |
| Revelation Partners | Series A |
| Corvex | Post Ipo Equity |
| ARK Investment Management | Post Ipo Equity |
| Illumina, Inc. | Post Ipo Equity |
| Novartis Pharma | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| Janus Henderson Investors | Post Ipo Equity |
| SoftBank Group Corp | Post Ipo Equity |
| T. Rowe Price | Post Ipo Equity |
| Counterpoint Global | Post Ipo Equity |
| Farallon Capital Management | Post Ipo Equity |
| Casdin Capital | Post Ipo Equity |
SomaLogic competitors
SomaLogic's top competitor, Robert Wood Johnson Foundation, earned an annual revenue of $619.0M.
SomaLogic's smallest competitor is American Thyroid Association with revenue of $3.7M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| J. Craig Venter Institute | $64,843 | $39.9M | 200 | 11 |
| Robert Wood Johnson Foundation | $50,430 | $619.0M | 270 | 6 |
| Baylor College of Medicine | $56,016 | $110.0M | 11,288 | 6 |
| American Public Health Association | $55,858 | $50.0M | 314 | 2 |
| American Gastroenterological Association | $63,552 | $21.0M | 144 | 1 |
| American Thyroid Association | $40,248 | $3.7M | 15 | - |
| National Academy of Medicine | $63,390 | $7.2M | 91 | - |
| Sage Therapeutics | $99,139 | $41.2M | 637 | 1 |
| Cell Signaling Technology | $79,146 | $48.0M | 500 | 3 |
| Cytokinetics | $89,800 | $18.5M | 130 | 20 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
SomaLogic highest paying jobs
Zippia gives an in-depth look into the details of SomaLogic, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SomaLogic. The employee data is based on information from people who have self-reported their past or current employments at SomaLogic. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SomaLogic. The data presented on this page does not represent the view of SomaLogic and its employees or that of Zippia.
SomaLogic may also be known as or be related to SOMALOGIC, INC, SOMALOGIC, INC., SomaLogic, SomaLogic Inc, SomaLogic, INC., SomaLogic, Inc., Somalogic and Somalogic, Inc.